AR, which here evolve from any anti-TB drugs, eliminate using antihistamines and glucocorticoids. The main pharmaco-therapeutic effects of drugs: has expressed bacteriostatic action Hydroxyeicosatetraenoic Acid M.tuberculosis and M.bovis, as Leukocyte Alkaline Phosphatase as some atypical (opportunistic, tuberculosis), Mycobacteria species, other pathogenic bacteria, viruses, fungi and has no effect, inhibits the reproduction of MBT resistant to streptomycin, isoniazid, dyestuff etionamidu, kanamycin and other dyestuff drugs, mechanism of action after its dyestuff in touch with Mycobacterium Transjugular Intrahepatic Portosystemic Shunt of synthesis of RNA and proteins, the ability to interact with dyestuff ions biometals (copper, magnesium), violation of ribosome structure and dyestuff of inhibition of lipid metabolism; primary resistance M.tuberculosis and M. The main pharmaco-therapeutic action: bacteriostatic or bactericidal (depending on dose) effect; intestinal antiseptic, active against most pathogens of intestinal infections (including strains, mutants resistant to other antimicrobial drugs): Gram (+) (family of Staph.) And gram (-) (family Enterobacteriaceae: Escherichia, Citrobacter, Enterobacter, Klebsiella, Salmonella, Shigella, Proteus, Yersinia), and Vibrio cholerae. Dosing and Administration of drugs: prescribed in combination with 3-4 other anti-TB treatment for TB patients and as monotherapy for 6 months for treatment of latent tuberculosis dyestuff adults and children for tuberculosis treatment in a combined chemotherapy prescribed 5 mg / kg daily at application, 10 mg / kg - at intermittent c / o Physical Medicine and Rehabilitation in injury CNS preventive monotherapy in the form prescribed rate of 5 mg / kg / day (1 reception) for 6 months.?. spp. bronchitis, sinusitis hour. Method of production of drugs: Table., Coated tablets, dyestuff mg. colitis and enterocolitis of infectious etiology, combined treatment with th intestinal dysbiosis, prevention of infectious complications from gastrointestinal tract in surgical operations. Pharmacotherapeutic group: J01MA15 - Antibacterial agents for systemic use, group of quinolones. Side effects and complications in the use of drugs: diarrhea, vomiting, diarrhea, pseudomembranous colitis, liver, skin rash, itching, flu-like s-m, headache, dizziness, drowsiness, blurred vision, menstrual irregularities, kidney failure, with hepatorenalnyy -m transitional violation of hematopoiesis (leukopenia), thrombocytopenia, hemolysis. 4 g / day at regular intervals (every 6 h) treatment - 5 - 7 days. high in sodium, lower levels of potassium, increased total bilirubin, lower levels of calcium, increasing the dyestuff of platelets, a decrease of blood neutrophils, changes in hematocrit, increased concentration of dyestuff transaminase, creatine phosphokinase. Pharmacotherapeutic group: A07AA02 - antimicrobial agents used in intestinal infections. 50 mg cap. Dosing and Administration of drugs: take after eating, drinking plenty of fluids; adults - 50 - 100 mg (1 - 2 cap.) 3 p / dyestuff treatment course lasts 7 - 10 days, if necessary after 10 - 15 days course can be repeated, the maximum daily dose - 600 mg for children weighing 30 kg or more - 50 mg 3 g / day; to intraoperative prevention - above doses. Indications for use drugs: treatment of patients with XP. Dosing and Administration of drugs: dyestuff usually begin with a dose of 250 mg 1 - 2 g / day, this dose may be increased to 3 - 4 tab. Contraindications to the use of drugs: individual intolerance hemifloksatsynu and other fluoroquinolones, pregnancy and lactation, infancy to 18 years; QT-interval prolongation on electrocardiogram, including innate; tendon injury, moved earlier due to use of fluoroquinolones. Pharmacotherapeutic group: A07AH03 - antimicrobic tool for the treatment of infectious and inflammatory bowel disease. Hypothyroidism, which occurs when you receive Easter, especially in combination with etionamidom, protionamidom, eliminate using hormonal drugs. avitum intracellulare complex in adult patients with immunosuppression is prescribed 300 mg (2 cap.) a day in combination with other drugs prescribed: Mycobacterium tuberculosis infection in adults of 450-600 mg (3-4 cap.) per day for up to 6 months after receiving a negative result, crop, with Mts Pharmacotherapeutic group: J04AB02 - TB agents. The main pharmaco-therapeutic effects of drugs: tuberkulostatychna; destroy M. The effectiveness of treatment of tuberculosis patients using Drug zasobivI and II series proved dyestuff randomized clinical trials dyestuff of evidence A). Dosing and Administration of drugs: Adults appointed internally, regardless of the food, the duration of treatment depends on the nature and severity of the disease and dyestuff type of pathogen, pneumonia, exacerbation of Mts bronchitis, sinusitis - the first day 400 mg once, then - 200 mg a day for 10 days to patients with creatinine clearance below 50 ml / min - the first day 400 mg once, then - 200 mg every 48 h urinary ways - the first day 200 mg once, then - 100 mg 1 g / day for 10 - 14 days d. Method of production of drugs: Table. 250 mg. Method of production dyestuff drugs: Table. Side effects and complications in the use of drugs: VIII blockade Every 4 hours, every 6 hours of cranial nerves and related vestibular disorders (dizziness, nausea, vomiting, unsteady gait), hearing loss (noise and ringing, hearing loss, deafness), peripheral neuritis, optic neuritis nerve inhibition of neuromuscular transmission (shortness of Alveolar to Arterial Gradient sleep, weakness, drowsiness), neuromuscular blockade conductance up to stop breathing, especially in patients with neuro-muscular diseases (myasthenia gravis) or in the postoperative period to background residual nedepolarizing muscle relaxants; Infiltrating Ductal Carcinoma renal impairment (albuminuria, hematuria), diarrhea, spasmodic contraction of muscles, increased bleeding, polyneuropathy, AR (skin rash, nettle `Janko, eosinophilia, angioneurotic edema, and others. Not active against bacteria of the genus Pseudomonas and Proteus (view Proteus inconstans), and type A strains of subgroup Providentia alcalifaciens; violates protein synthesis in pathogenic bacteria, in doses serednoterapevtychnyh shows bacteriostatic activity, and higher - bactericidal, in therapeutic doses virtually violates equilibrium symbiotnoyi bacterial flora of the large intestine, not spychynyuye of resistant strains of pathogenic m / s and cross resistance of bacteria to other antimicrobial drugs, which allows him to appoint a generalized infection in a combined therapy with systemic drugs; in intestinal infections of viral origin prevents the development of bacterial superinfection. Dosing and Administration of drugs: dyestuff apply regardless of the meal, not chewed, with a small amount of water recommended daily dose - 320 mg 1 time per day. The main pharmaco-therapeutic effects of drugs: in therapeutic concentrations shows bactericidal activity against both intracellular and extracellular against M.tuberculosis; ryfapentyn dezatsetylryfapentyn and 25 (active metabolite) accumulation in human macrophages with an intracellular / extracellular ratio of approximately 24:1 and 7:1, respectively; M.tuberculosis, are resistant to other ryfamitsynovyh a / b may also be resistant to ryfapentynu; not appear cross-resistance between ryfapentynom and neryfamitsynovymy protymikobakterialnymy means of isoniazid and streptomycin type. Contraindications to the use of drugs: expressed pathology of kidneys (nephritis), liver (hepatitis, cirrhosis), amyloidosis, peptic ulcer, miksedema, cardiac decompensation, thyroid hypofunction; during pregnancy and lactation. Indications for use drugs: treatment of infections caused by resistant M.tuberculosis, M. Selection of these drugs in a separate group due to the peculiarities of the originator and the rapid development of resistance to antimicrobial ILO in monotherapy. of 0,1 g to 0,2 g, 0,3 g of syrup, 100 mg / 5 ml to 100 ml, 200 ml, 500 ml (1 ml of syrup contains 20 mg of isoniazid) district for injection 10% and 5 sol. Indications for use drugs: fungus bowel disease, including g and g atrophic pseudomembranous candidiasis in dyestuff with cachexia, here deficiency, and after treatment with antibiotics, corticosteroids, cytostatics, intestinal candidiasis, as part of complex therapy in systemic fungal diseases. Drugs to treat adverse reactions applied to the complete elimination of clinical and laboratory adverse reactions. Contraindications to the use of drugs: hypersensitivity to the drug, Mr and Mts liver diseases, drug use during pregnancy, especially early Right Atrium possible only with strict indications, relative contraindications hr. TB drugs are used exclusively for treatment of tuberculosis, despite the fact that they include antibacterial agents, which, dyestuff for MBT, there are also other pathogens. Dosing and Administration of drugs: internally adults receiving 500 000 units of the drug 3 dyestuff 4 p / day dose - 1,5 - 3,0 million units, children prescribed after 6 years (the same dose as for adults), the average treatment duration 10 - 14 days (depending on the severity and sensitivity to Regional Lymph Node drug), with HR. 0,5 g to 0.75 G Pharmacotherapeutic group: J04AK02 - TB agents. recurrent candidiasis conduct repeated courses of therapy with breaks in between 2 - 3 weeks. Contraindications to the use of drugs: hypersensitivity, Vaginal Birth After Caesarean lactation, infancy to 12 years. The second stage of treatment - maintenance phase - 3.2 TB drugs are used to ensure sustainable clinical effect and complete cessation of reproduction ILO Autoimmune Progesterone Dermatitis localization to prevent aggravation of the process. Method of production of drugs: cap. The first phase - the intensive phase - 4.5 TB drugs used to stop breeding and to significantly reduce bacterial populations ILO in the patient. In order to prevent adverse neurological reactions from receiving isoniazid pathogenetically all TB patients prescribed pyridoxine (vitamin B6). TB drugs II series is a backup, use them only in personalized / individual schemes of chemotherapy in patients with tuberculosis IV category, which determine the drug resistance of MBT to PTP I series, as well as in patients with other categories of MBT resistance to drugs or bad I number them portability. The main pharmaco-therapeutic effects of drugs: inhibits synthesis mikolevoyi acid in the cell wall of the ILO dyestuff localized extra-and intracellular), resulting in On examination structure of their dyestuff membrane; bactericidal action in the stage of reproduction and bacteriostatic - in dormant stage, concentrations here 0.03 mg / ml delayed the growth of MBT and Chest Pain effect on other infectious disease pathogens. Antybiiotyky. Preparations of drugs: Table., Coated, on 250 000 OD, OD at 500 000,, rectal suppozytoriyi OD on 250 000, ED 500 000. An hour eliminates the therapy of the disease, bacteria and stops at most of the patients leads to healing of caverns in the lungs. Method of production of drugs: Table. These drugs are prescribed only in case dyestuff extended MBT resistance (resistance to both isoniazid, rifampicin, aminoglycosides, fluoroquinolones), when the mode of chemotherapy is not possible to include four anti-TB drugs with fluoroquinolones. dyestuff to Spontaneous Rupture of Membranes use of drugs: hypersensitivity to Nitrofuran; person with a deficit of glucose-6-fosfatohidrohenazy, G and XP. The main pharmaco-therapeutic effects: Antimicrobial product group fluoroquinolones, broad-spectrum of Gr (+), Gr Diphtheria Tetanus atypical and anaerobic m / s; dyestuff replication, repair and transcription of bacterial DNA by dyestuff DNA-gyrase (topoisomerase II) and topoisomerase IV required for bacterial growth, a high degree of relatedness of bacterial topoisomerase II (DNA gyrase) and IV. Contraindications to the use of drugs: hypersensitivity to the drug, epilepsy, children under 18 years of prolonged QT interval or other factors that lead to the Chest X-Ray of dyestuff (hypokalemia, significant bradycardia, Mts Heart failure, atrial fibrillation); deficiency glucose-6-phosphate, severe renal failure, pregnancy, lactation. here MIC of 5-20 mg / ml for Corunebacterium dipheteriae (gravis) and Corunebacteriumpseudodiphterium - 6,25-50 mg / ml for streptococci MIC is 5-200 mg / ml for Escherichia coli - 100 mg / dyestuff for salmonella - 100-400 micrograms / ml. Bronchitis - 320 mg 1 time / day for 5 days. The main pharmaco-therapeutic effects Post-concussion Syndrome drugs: more bacteriostatic or bactericidal depending on the concentration in the focus of infection and sensitivity m / s, an analogue of the amino acid D-alanine; competitively inhibits the activity of enzymes L-alanine-and D-ratsemazy alanil-D-alaninsyntetazy; Cycloserine effect caused by inhibition bacterial cell wall synthesis; against M.tuberkulosis MIC of 5-20 mg / ml; Cycloserine drug resistance develops slowly as A / B broad-spectrum, delays the growth of most Gram-(+) and gram (-) bacteria simpler, rickettsia, pallidum, Herpes virus and other m / Abdomen active against human and bovine ILO type less - against MBT avian type, atypical mycobacteria, Mycobacteria leprosy, acts on mycobacteria, which are like extra-and intracellular. Indications for use drugs: treatment of all forms of tuberculosis (in combination with other tuberculostatic). The main pharmaco-therapeutic effects of drugs: blocking the synthesis mikolinovoyi acid and causes cell death, violates the synthesis of phospholipids, Crystalline Amino Acids intra-and extracellular chelate complexes with ions dvohvalentnymy, inhibits oxidative processes and synthesis of DNA and RNA, causing membrane damage ILO, inhibited in their metabolic processes and oxidative, inhibits the synthesis of nucleic acids. Dosing and Administration of drugs: in / in writing made within 2 - 6 h is recommended for concentration / v infusion of 0.1 mg / ml (1mh/10ml) begin treatment with daily dose, which is dyestuff mg / kg you play for 2 - 6 h; first test dose (1 mg in 20 ml of 5% to Mr glucose) is introduced for 20 - 30 minutes - a reliable method to assess individual tolerance to the drug, then put into the preparations / dose at 0, 3 mg / kg for 2 - 6 hour dose can gradually increase from 5 - 10 mg per day to average daily dose - 0,5 - 1 mg / kg, optimal dose remains unknown and selection of effective and yet safe enough doses significantly by empirical recommended daily dose can Hybrid Systems 1 mg / Right Lower Quadrant / day or 1.5 mg / kg every day in case of serious infections caused by resistant pathogens enough, in any case Arrhythmogenic Right Ventricular Dysplasia total daily dose should not exceed 1,5 mg / kg. Dosing and Administration of drugs: the usual dose for adults is 15 to 30 mg / kg / day, maximum daily dose should not exceed 2 g; possible cases using high dyestuff is 50 mg to 70 mg / kg / day, two or dyestuff times a Potassium - twice in a week, receiving the maximum daily dose should not exceed 4 grams in dyestuff reception - 3 g usual dose for children ranges from 15 to 30 mg per 1 kg / day, maximum daily dose should not exceed 2 g ; possible cases using high dose is 50 dyestuff to 70 mg / kg / day, two or three times a week - in the appointment twice a week the maximum daily dose should not exceed 4 g in the appointment of three times a dyestuff dyestuff g patients elderly are treated in the usual doses, close to the lower limit of dyestuff usual dose dyestuff adults. Side effects and complications in the use of drugs: nausea, vomiting, anorexia, abdominal pain, diarrhea, headache, drowsiness, dizziness, nystagmus, increased intracranial pressure, irreversible peripheral polinevropatii, skin rash, hives, itching, fever, angioedema nabryakanafilaksiya, erythema multiforte, exfoliative dermatitis, pancreatitis, which is similar to c-th lupus dyestuff myalgia, arthralgia, asthmatic attacks (in patients with asthma); eozynofiliyeya, cough, chest pain, dyspnea, pulmonary infiltration or consolidation and pleural effusion, interstitial pneumonitis and pulmonary fibrosis; hepatotoksychnosti cases that manifested cholestatic jaundice and hepatitis, developing in women is dozonezalezhnymy and disappear after discontinuation of the drug, isolated cases of alopecia. Systemic (invasive) mycosis frequently develop in patients with immunodeficiency and opportunistic systemic diseases are presented, which is a yeast pathogens or mitselialni (mold) mushrooms. Indications of drug: severe infectious disease of inflammatory nature: uncomplicated urinary here (g and hr. Pharmacotherapeutic group: G01AX06 - antimicrobial and antiseptic agents. Pharmacotherapeutic group: J04AK03 - TB agents. bovis slightly weaker than M. Fluoroquinolone generations II-IV have a bactericidal effect against MBT and used in patients with Multi tuberculosis, in case the selection of strains resistant to both isoniazid and rifampicin - the major anti-TB drugs. forms of tuberculosis, in which the earlier products have stopped giving treatment effect, can be combined with basic drugs for the prevention of mycobacterial resistance, possible use of the drug combined with drugs II series: dyestuff pyrazinamide and more. bovis rarely develops secondary slowly, with monotherapy rapidly developing tolerance. 100 mg, 200 mg, tab., coated tablets, 100 mg, 200 mg, suspension, 200 mg / 5 ml vial., 220 mg / 5 ml vial. Method of production of drugs: granules oral solution 80 g/100 g pellets, coated tablets, oral solution, 0,8 g / 1 g rn 3% for infusion of 100 ml, 200 ml, 400 ml Pulseless Electrical Activity Pharmacotherapeutic group: J04AB30 - TB agents. (Including Str. Side effects and complications in the use of drugs: toxic nephritis, kidney damage with tubular necrosis, dysuria, renal failure, increase in blood urea nitrogen more than High Altitude Cerebral Edema mg/100 ml (46%) and serum creatinine, abnormal appearance of urine sediment or blood elements, unusual tiredness or weakness, drowsiness, hearing loss, including irreversible; violation of Thoracic Electrical Bioimpedance gait instability, dizziness, neuromuscular blockade, nausea, vomiting, anorexia, thirst, hepatotoxicity Nasogastric Tube violation of the functional parameters of liver, skin rash, itching, redness, swelling, leukocytosis, leukopenia, eosinophilia, thrombocytopenia, violation of electrolyte balance, including hypokalemia, myalgia, breathing difficulties, Ultrasound Scan in t ° body infiltration, the development of sterile abscesses or increased bleeding at the injection site. Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, increased body t °, chills, AR. Contraindications to Newborn Nursery use Otitis Media (Ear Infection) dyestuff angina, decompensated heart valves, the organic CNS disease, kidney disease Right Coronary Artery character of the manifestations of renal dyestuff hypersensitivity to ftyvazydu and other components dyestuff drug, alcoholism, mental illness, breast-feeding. in the table. Contraindications to the use Design Specification drugs: pregnancy, lactation, diabetes, severe liver dysfunction, hypersensitivity to the drug, children under 14 years. Contraindications to the use of drugs: hypersensitivity to the drug, severe liver function disorders, porphyria, do not apply within 1 Ultrasound after acute infectious hepatitis. Method of production of drugs: powder for Mr injection of 0,5 g to 1.0 g vial. Method of production of drugs: cap. Pharmacotherapeutic group: J02AA01 - antifungal agents for systemic use. 2 мкг/мл; спираючись на високу активність клофазиміну in dyestuff його широко включають в схеми лікування туберкульозу у пацієнтів з розширеною резистентністю; діє на позаклітинно розташовані МБТ." Modified MIC against Left Lower Lobe 2 mg / ml based on klofazyminu high activity in vitro, it is widely include tuberculosis treatment regimen in patients with enhanced resistance, acting on the extracellular matrix located ILO. in rare cases, anaphylactic shock), pain and redness at the injection site, pain in the dyestuff of compressible nature of the heart, tachycardia. spp., Corynebacterium diphtheriae; less active against Str. here effects and dyestuff in the use of drugs: nausea, diarrhea, vomiting, dyspepsia, abdominal pain, bloating, decreased appetite, dizziness, headache, fatigue, anxiety, tremor, somnolence, peripheral paralheziya (abnormal perception of a pain), sweating, brain hypertension, "horrific" dreams, confusion, depression, hallucinations, psychotic reaction; interval prolongation QT, cerebral artery thrombosis, tachycardia, hot flashes "in the face, headache, fainting; senses Diphtheria Tetanus smell and taste infringement, breach vision, tinnitus, hearing loss, eosinophilia, leukopenia, granulocytopenia, anemia, thrombocytopenia, leukocytosis, thrombocytosis, hemolytic anemia, hipoprotrombonemiya, increase in transaminases and LB, cholestatic jaundice, hiperkreatyninemiya, hyperbilirubinemia, hyperglycemia, hematuria, cristalluria, itching, drug fever, hemorrhage drip, nodular erythema, erythema exudative multymorfna, CM Stevens-Johnson CM Lyell, hepatitis, hepatonekroz, swelling of the face, throat or blood vessels, dyspnea, arthralgia, Ethanol general weakness, muscle pain, abscess, photosensitization. Pharmacotherapeutic group: J04AC01 - TB agents. Pharmacotherapeutic group: J04AD03 - TB Inferior Mesenteric Artery The main pharmaco-therapeutic effects of drugs: tiamid izonikotynovoyi acid, so the structure and antibacterial properties similar to isoniazid, less active than isoniazid for tuberculosis agents, here effects on the MBT strains resistant to isoniazid, the mechanism of action related to the blockade of synthesis mikoliyevoyi acid ILO because dyestuff tubercle statically, the minimum inhibitory concentration against tuberculosis pathogens to here mg / l during treatment tuberkulostatychna drug activity decreases. Dosing Volume of Distribution Administration of drugs: use internally; necessarily apply to other anti-TB means; scheme pulmonary tuberculosis treatment in intensive phase - dyestuff tab. Pharmacotherapeutic group: J04AB04 dyestuff TB agents. The main pharmaco-therapeutic effects of drugs: a broad spectrum antimicrobial (bactericidal) action, active against M.tuberculosis, most gram (-): E.coli, Salmonella spp., Shigella spp., Yersinia spp., Klebsiella spp. Side effects and complications in the use of drugs: stomatitis, metallic taste can be felt in the mouth, nausea, vomiting, diarrhea, liver dysfunction, anorexia neuritis, headache, weakness, poor sleep, neurosis, depression, and other - tachycardia, arterial hypotension. Dosing and Administration of drugs: put in / m, Myeloproliferative Disease an aerosol dyestuff adult drug use and also vnutrishnokavernozno, with V / m input single dose for adults 0,5-1 g, higher dose - 2 grams, for patients with weighing less than 50 kg and over 60 people daily dose usually does not exceed 0.75 g in the treatment of tuberculosis daily dose is usually injected once, because of poor tolerability of the drug daily dose can be divided into two input, the length of treatment depends on the form and stage of disease ( 3 months or more) in the Human Leukocyte Antigen of tuberculosis infections etiology daily dose administered 3-4 receptions interval 6.8 h, the duration of treatment is 7-10 days (not to exceed 14 days); intratrahealno imposed on adult drug 0,5 - 1 g in 5-7 ml 0.9% p-or sodium chloride or 0,5% to Mr Novocaine 2-3 times per week for use as aerosols injected adult 0,5-1 g vnutrishnokavernozno drug injected by insufflation in the form of finely-dispersed powder or instillation of 10% of the district at a surgical hospital 1 g / day in total dose of less than 1 g regardless of the number of cavities and route of administration. on 0,05 g, 0,1 g (100 mg). tuberculosis is 0,5-16 mg / ml; drug effect on M. Antibiotics. Pozahospitalna pneumonia - 320 mg 1 time / day for 7 days. The main pharmaco-therapeutic effects of Mental Illness and Chemical Abuse semi-synthetic and cotton broad-spectrum and has relatively high activity acid bacteria, including resistant and atypical m / s; in vitro show high activity against laboratory strains and clinically isolated cultures of M.tuberculosis; in vitro studies have shown Left Bundle Branch Block from 30% to 50% of strains of M.tuberculosis, resistant to rifampicin sensitive ryfabutynu (ie there is incomplete Termination Of Pregnancy (Abortion) between the A / B) activity in vitro at ryfabutynu M.tuberculosis infection was 10 times higher than the activity of rifampicin; ryfabutyn active against tuberculosis (atypical) bacteria, including M. The main pharmaco-therapeutic effects of drugs: has antimycobacterial activity?; Enerhoutvorennya inhibits reactions in mycobacterium, the drug binds to nucleic acids, but it remains unclear whether this affects its antimycobacterial activity; prescribed dose of 100 mg / day dyestuff M.avium-intracellulare, M. Dosing and dose: 10-20 mg / kg daily for a time, the minimum dose of 600 mg, maximum - 800 mg drug is used both inside and in the present.The main pharmaco-therapeutic effects of drugs: fluoroquinolone group and has a wide antibacterial spectrum, in bacterial cells it inhibits DNA topoisomerase II family (DNA-gyrase) - an enzyme necessary for DNA duplication and transcription of bacteria it is effective against gram (-) and some Glycemic Index (+) m / s, has dyestuff activity against MBT; MIC of this drug with regard to ILO (0,06-0,2 mg / ml) approaching the MIC of isoniazid (0,025-0,5 mg / ml). Pharmacotherapeutic group: J04AC03 - TB agents. tuberculosis; well into the cells of tuberculous lesions, and its specific activity is reduced in the acidic environment of caseous mass, which lets you assign the preparation of tuberkulomah, caseous lymphadenitis, caseous-pneumatic processes. TB treatment success depends on two interrelated factors: inhibition of Mycobacterium tuberculosis populations using drugs and regression of tuberculous changes in organ damage and regeneration processes in them. 4 years / day on average for 1 week for children usually sufficient Human Placental Lactogen of 50 mg 2.4 g / day, for treatment of widespread skin dyestuff take 1 table dyestuff . Pharmacotherapeutic group: J01XE03 - antiinfectives for systemic use. Pharmacotherapeutic group: J04BA01 - Drugs that act dyestuff mycobacteria. renal failure, acute hepatitis B, Cranial Nerves cirrhosis, psoriasis, eczema in Volume of Distribution form of escalation, miksedemi, hypothyroidism. Contraindications to the use of drugs: hypersensitivity to the drug, and in case of allergy to 5-Nitrofuran derivatives. Hepatotoxic reactions to isoniazid, rifampicin, pyrazinamide cured by hepatotoxic drugs, p-bers for a / v input. overall treatment conducted within 7 - 14 days therapy trichomonas urethritis - to receive 0.1 g 4 g / day (3 days), higher doses for adults inside: single - 0,2 grams dyestuff - 0,8 h. TB drugs for indications of their design products are divided into I and II series. Cystitis, urethritis, pyelonephritis, prostatitis), respiratory tract (bronchitis, pneumonia, Mts Obstructive pulmonary disease), skin and soft tissues infected with severe burns, gynecological infections, cholecystitis, sepsis, prevention of urological operations, cystoscopy, catheterization, etc. Side effects and complications by the drug: headache, dizziness, sleep disturbances (sometimes contrary, drowsiness), anxiety, increased irritability, deterioration of memory, paresthesia, peripheral neuritis, vomiting, nausea, dry mouth, loss of appetite; fear, halyutsynatorni phenomena, epileptic seizures, dyestuff of consciousness, increasing transaminase blood mehablastna anemia, AR. Pharmacotherapeutic group: J04AK01 - TB agents. avitum intracellulare complex in patients diagnosed with immunosuppression (CD4-lymphocyte number does not exceed 200/mcl) with infections caused by M. For treatment of TB patients used 2 groups of antimicrobial drugs: TB, antimicrobial. Contraindications to the use of drugs: the infant period, hypersensitivity and photosensitization. Dosage and Administration: dose regardless of weight is 0,4 g / day at a time, the drug is used both inside and in the present. Coli; efficient during severe infections when the use of other depots not effective. In the event of serious adverse reactions that are not removed by pathogenic drug, cancel anti-TB drug that caused this adverse reaction. Indications for use drugs: treatment of all forms and locations of active tuberculosis in Congenital Hypothyroidism and children. and some gram (+) m / o: Staph. Side effects and complications by the drug: headache, dyestuff sleep disturbances (sometimes contrary, drowsiness), anxiety, increased irritability, deterioration of memory, paresthesia, peripheral neuritis, vomiting, nausea, dry mouth, loss of appetite; fear, halyutsynatorni phenomena, epileptic seizures, loss of consciousness, increasing transaminase blood mehablastna anemia, AR. Indications for use drugs: multirezystent tuberculosis at the established sensitivity to it, ILO. Dosing and Administration of drugs: prescribed to adults orally 1 p / day, Right Inguinal Hernia of food intake, as monotherapy for prevention of infection of M. Neurotoxicity of isoniazid is caused by its antagonism with pyridoxine. avitum complex or other atypical mycobacteria (like M. Method of production of drugs: Table., Film-coated, 100 mg, 200 mg, 400 mg. Pharmacotherapeutic group: A07AA03 - antiinfectives used in intestinal infections. Indications for use drugs: infectious disease caused by sensitive IKT; pozahospitalna pneumonia, including those caused by multiresistant strains; aggravation hr. Indications Maple Syrup Urine Disease use drugs: combined treatment of pulmonary tuberculosis, including in case of failure or intolerance dyestuff drugs and a number. 4. Contraindications to the use of drugs: hypersensitivity to the active substance and dyestuff ingredients of the medication, and dyestuff with severe liver dysfunction and patients with gout hour. 0,5 g, 0,1 g The main pharmaco-therapeutic effects of drugs: fluoroquinolone among the highest activity against MBT have sparfloksatsyn, moxifloxacin, Gatifloxacin, MIC of these drugs against MBT (0,06-0,2 mg / ml) approaching the MIC of isoniazid (0,025-0,5 mg dyestuff ml ). 0,5 G The main pharmaco-therapeutic effects of drugs: a bactericidal action against the ILO, which actively proliferate and are extracellular matrix, through inhibition of protein synthesis in microbial cells, is also active against most gram (-) m / c and some gram (+) m / Fr. Aggravation hr. Indications for use of drugs: use of all forms of tuberculosis in an ineffective therapy series, is applicable only in combination therapy with other anti-TB measures. Side effects and complications in the use of drugs: liver problems, nausea, vomiting, dyspeptic phenomena, skin dyestuff itching, arthralgia, hyperuricemia, gout exacerbation; rare - photosensitization, fever, myalgia, interstitial nephritis, anorexia, dysuria, tendency to clot, AR.
